AUBREE GAUDEN: Open Payments
NPI 1174996912 · ROSTRAVER TOWNSHIP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 39 payments from 18 companies in 2025. Trend: 2023 $106 · 2024 $341 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $261 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
| Amgen Inc. | 2 | $49 |
| Abbott Laboratories | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| PFIZER INC. | 2 | $31 |
Products named: Wegovy, TRELEGY ELLIPTA, KEVEYIS, Rybelsus, Ozempic, FREESTYLE LIBRE 3, INSPIRE, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
